Analyst Insights
Cns Pharmaceuticals Inc (CNSP) with a beta value of 1.05 appears to be a promising investment opportunity.
A new trading day began on Monday, with Cns Pharmaceuticals Inc (NASDAQ: CNSP) stock price up 19.67% from the previous day of trading, before settling
